More Stories

Informist, Monday, Mar. 23, 2026

MUMBAI –

Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., and several other companies have launched semaglutide injections in India under different brand names. Other companies include Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Alkem Laboratories Ltd., and Torrent Pharmaceuticals Ltd., according to exchange filings.

The injections, depending on the brand and dose size, cost between INR 325 and INR 2,000 for a week's treatment. Semaglutide injection is used to treat type-II diabetes and reduce weight. 

Sun Pharmaceutical Industies had the costiliest product with its injection, under the brand name Noveltreat, costing INR 900-INR 2,000 for a week's treatment for different dozes. It has also launched the injection under its affordable brand 'Sematrinity' which will cost INR 750-INR 1,300 for a week's treatment.  

Dr. Reddy's has launched the injection under 'Obeda' brand in two strengths of 2 milligrams and 4 mg. This will come in pre-filled and disposable pens and cost INR 4,200 a month for both strengths. Each pen is capable of four weekly doses.

Among smaller companies, Glenmark Pharma has launched the product in the form of vials and pre-filled pens. The vials will cost INR 325-INR 440 for a week's treatment.

Torrent Pharma's product will be available as a pre-filled pen under three brands--Semasize, Obesema, and Hepaglide--and will cost INR 450 for a week's treatment. Zydus Life also launched the product under three brands--Semaglyntm, Mashematm and Alterme--and these will cost INR 2,200 for a month.

Shares of the six pharmaceutical companies closed 0.3-4% higher on Friday, ahead of the product launch. Shares of Dr. Reddy's and Sun Pharma had ended nearly 2% higher on the National Stock Exchange at INR 1,298.90 and INR 1,777.10 per share.  End

Reported by Anshul Choudhary

Edited by Avishek Dutta

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

© Informist Media Pvt. Ltd. 2026. All rights reserved.